Nevro Corp (NVRO) Stock
NVRO is no longer traded. Nevro was delisted from the NYSE in March 2025.
Prices on this page are historical; the last trade was March 27, 2025 at $5.84.
Nevro stock price history
NVRO final trading statistics
- Final close
- $5.84
- Final trading day
- Mar 27, 2025
- Market cap at delisting
- $224.09M
- Shares outstanding
- 38.37M
- Final 52-week range
- $3.17 – $14.70
- Avg. volume (final 3 mo.)
- 1,224,648
- All-time high (split-adj.)
- $184.34 · Dec 2020
- All-time low (split-adj.)
- $3.29 · Jan 2025
- Return since IPO
- -76.8%
- Beta
- 0.82
- Book value / share
- $6.11
- Price / book
- 0.96
Nevro annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2024 | $408.52M | -$113.4M | -$2.17 |
| FY2023 | $425.17M | -$92.2M | -$2.57 |
| FY2022 | $406.37M | $3.0M | -$0.01 |
| FY2021 | $386.90M | -$131.4M | -$3.19 |
| FY2020 | $362.05M | -$83.1M | -$2.49 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Nevro Corp
Nevro Corp., a medical device company, engages in the provision of products for patients suffering from chronic pain in the United States and internationally. The company provides HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic back and leg pain through paresthesia-free 10 kHz therapy, as well as offers Senza II and Senza Omnia SCS systems. It also offers Senza HFX iQ platform that includes HFX iQ implantable pulse generator, HFX trial stimulator, and HFX iQ patient remote, as well as HFX App, a patient remote control and the wireless trialing system. In addition, the company provides HFX AdaptivAI, a pain management platform that powers the HFX iQ SCS system, as well as surpass surgical and percutaneous leads. It sells its products through its direct sales force, and a network of sales agents and independent distributors. The company was incorporated in 2006 and is based in Redwood City, California.
Nevro stock FAQ
What happened to Nevro stock?
Nevro stock was delisted from the NYSE. Its final close was $5.84 on March 27, 2025.
Is NVRO stock still trading?
No. NVRO was delisted from the NYSE in March 2025 and no longer trades on a U.S. exchange.
What was the last price of NVRO stock?
NVRO closed at $5.84 on its final trading day, March 27, 2025, for a market value of about $224.09M.
What were Nevro's revenue and earnings in its last full fiscal year?
Nevro reported revenue of $408.52M and net income of -$113.4M in fiscal 2024, its last full year as a public company.
When did Nevro go public?
Nevro Corp stock began trading on November 6, 2014.